{"id":222,"date":"2026-04-23T09:31:42","date_gmt":"2026-04-23T09:31:42","guid":{"rendered":"https:\/\/asceticit.shop\/wp2\/?post_type=product&#038;p=222"},"modified":"2026-04-25T19:14:55","modified_gmt":"2026-04-25T19:14:55","slug":"olanib_special_oncology","status":"publish","type":"product","link":"https:\/\/asceticit.shop\/wp2\/product\/olanib_special_oncology\/","title":{"rendered":"Olanib"},"content":{"rendered":"<p><strong data-start=\"729\" data-end=\"753\">1. Product Overview:<\/strong> Olanib is a capsule formulation of Olaparib INN 50 mg, a targeted anticancer agent belonging to the class of PARP inhibitors used in BRCA mutation\u2013associated cancers.<\/p>\n<p><strong data-start=\"923\" data-end=\"942\">2. Composition:<\/strong> Active Ingredient: Olaparib INN 50 mg | Dosage Form: Capsule<\/p>\n<p><strong data-start=\"1006\" data-end=\"1035\">3. Pharmacological Class:<\/strong> PARP (Poly ADP-Ribose Polymerase) Inhibitor<\/p>\n<p><strong data-start=\"1082\" data-end=\"1109\">4. Mechanism of Action:<\/strong> Olaparib inhibits PARP enzymes involved in DNA repair. This leads to accumulation of DNA damage in cancer cells, inability to repair, and selective cancer cell death, especially in BRCA-mutated tumors.<\/p>\n<p><strong data-start=\"1314\" data-end=\"1333\">5. Indications:<\/strong> Ovarian cancer with BRCA mutation | HER2-negative breast cancer with BRCA mutation | Pancreatic cancer with germline BRCA mutation | Prostate cancer with HRR gene mutations<\/p>\n<p><strong data-start=\"1509\" data-end=\"1540\">6. Dosage &amp; Administration:<\/strong> As prescribed by oncologist | Oral use | Swallow whole with water | With or without food<\/p>\n<p><strong data-start=\"1632\" data-end=\"1657\">7. Clinical Benefits:<\/strong> Targeted cancer therapy | Delays disease progression | Improves progression-free survival | Oral convenience<\/p>\n<p><strong data-start=\"1769\" data-end=\"1794\">8. Contraindications:<\/strong> Hypersensitivity to Olaparib or any component<\/p>\n<p><strong data-start=\"1843\" data-end=\"1862\">9. Precautions:<\/strong> Use under oncologist supervision | Monitor blood counts regularly | May cause anemia or fatigue | Avoid use in pregnancy<\/p>\n<p><strong data-start=\"1986\" data-end=\"2012\">10. Drug Interactions:<\/strong> CYP3A inhibitors (ketoconazole) | CYP3A inducers (rifampicin, phenytoin)<\/p>\n<p><strong data-start=\"2088\" data-end=\"2116\">11. Special Populations:<\/strong> Pregnancy contraindicated | Lactation not recommended | Pediatric safety not established | Dose adjustment in renal\/hepatic impairment<\/p>\n<p><strong data-start=\"2254\" data-end=\"2278\">12. Adverse Effects:<\/strong> Nausea | Fatigue | Anemia | Decreased appetite<\/p>\n<p><strong data-start=\"2328\" data-end=\"2355\">13. Storage Conditions:<\/strong> Store below 30\u00b0C | Protect from light and moisture | Keep out of reach of children<\/p>\n<p><strong data-start=\"2441\" data-end=\"2459\">14. Packaging:<\/strong> Capsule in blister or bottle pack<\/p>\n<p><strong data-start=\"2496\" data-end=\"2517\">15. Manufacturer:<\/strong> Everest Pharmaceutical Ltd.<\/p>\n","protected":false},"excerpt":{"rendered":"<p data-start=\"242\" data-end=\"461\"><strong data-start=\"242\" data-end=\"253\">Olanib\u00ae<\/strong><br data-start=\"253\" data-end=\"256\" \/><strong data-start=\"256\" data-end=\"273\">Generic Name:<\/strong> Olaparib<br data-start=\"282\" data-end=\"285\" \/><strong data-start=\"285\" data-end=\"298\">Strength:<\/strong> 50 mg<br data-start=\"304\" data-end=\"307\" \/><strong data-start=\"307\" data-end=\"323\">Dosage Form:<\/strong> Capsule<br data-start=\"331\" data-end=\"334\" \/><strong data-start=\"334\" data-end=\"347\">Category:<\/strong> Targeted Anticancer Therapy<br data-start=\"375\" data-end=\"378\" \/><strong data-start=\"378\" data-end=\"390\">TG Name:<\/strong> Anticancer (PARP Inhibitor)<br data-start=\"418\" data-end=\"421\" \/><strong data-start=\"421\" data-end=\"432\">Status:<\/strong> Prescription Only Medicine<\/p>\n<p data-start=\"463\" data-end=\"803\"><strong data-start=\"463\" data-end=\"486\">1. What is Olanib\u00ae?<\/strong><br data-start=\"486\" data-end=\"489\" \/>Olanib\u00ae is a capsule containing Olaparib INN 50 mg. It is used for the treatment of ovarian, breast, pancreatic, and prostate cancers associated with BRCA gene mutations. It works by inhibiting PARP enzymes responsible for DNA repair, leading to cancer cell death. To be used as directed by a registered physician.<\/p>\n","protected":false},"featured_media":220,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[19,22],"product_tag":[],"class_list":{"0":"post-222","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-oncology","7":"product_cat-specialized-product","9":"first","10":"instock","11":"shipping-taxable","12":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/asceticit.shop\/wp2\/wp-json\/wp\/v2\/product\/222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/asceticit.shop\/wp2\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/asceticit.shop\/wp2\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/asceticit.shop\/wp2\/wp-json\/wp\/v2\/comments?post=222"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asceticit.shop\/wp2\/wp-json\/wp\/v2\/media\/220"}],"wp:attachment":[{"href":"https:\/\/asceticit.shop\/wp2\/wp-json\/wp\/v2\/media?parent=222"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/asceticit.shop\/wp2\/wp-json\/wp\/v2\/product_brand?post=222"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/asceticit.shop\/wp2\/wp-json\/wp\/v2\/product_cat?post=222"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/asceticit.shop\/wp2\/wp-json\/wp\/v2\/product_tag?post=222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}